An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm, according to research presented at the American Stroke Association's International Stroke Conference 2012.
Clazosentan reduces risk of blood vessel spasm in patients with brain aneurysm